Objective: To examine the hypothesis that insulin and insulin-like growth factor I (IGF-I) attenuate endothelin-induced contraction of porcine coronary epicardial arteries in vitro. Background: Endothelin-induced coronary vasoconstriction is mediated by two types of receptors, A (ETA) and B (ETB), resulting in calcium influx. Both insulin and IGF-I attenuate endothelin-induced calcium influx into porcine coronary artery smooth muscle. Methods: Epicardial arteries harvested from juvenile pigs were contracted with cumulative 10 M). In additional experiments, endothelin-1 or sarafotoxin-6c were added after incubation with 10 M regular insulin or IGF-I. These experiments were repeated in vessels without endothelium. Contraction for each vessel was calculated relative to the response to 60 mM KCl. Results: The maximal contractions to endothelin-1 in vessels with and without endothelium were 15868 and 200621%,
Introduction
isoform, while the ETB receptor has similar affinities for all ET isoforms [5] . ET-induced vasoconstriction is meEndothelin-1 (ET-1) is a 21 amino acid peptide, cleaved diated by calcium influx [2] . from a 39 amino acid precursor, big ET-1, through Insulin-like growth factors I (IGF-I) and II are 7.5 kDa proteolytic processing [1, 2] . ET-1 is a potent coronary peptides; both are highly homologous in structure and vasoconstrictor at pathophysiologic concentrations [3] . The function to proinsulin [7] [8] [9] . The peptides belonging to the effects of ET on vascular tone are mediated by two major IGF family interact with specific receptors designated as types of ET receptors, A (ETA) and B (ETB), each type I and II IGF receptors, as well as with the insulin encoded by a different gene [4, 5] . The two receptor receptor [7] . The type I IGF receptor binds IGF-I with high subtypes have distinct tissue distributions and affinities to affinity and insulin with low affinity, whereas the insulin ET isoforms: ETA receptors are present on vascular receptor binds IGF-I with a much lower affinity than smooth muscle cells, whereas ETB receptors are found on insulin. Both insulin and IGF-I have diverse vasoactive both vascular smooth muscle and endothelial cells [6] . The properties, ranging from vasodilatation to vasoconstriction, ETA receptor is selective for the ET-1 over the depending on the species examined, as well as on the particular vascular bed [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] .
27
Prior studies have demonstrated an interaction between Mountainview, CA, USA) or 10 -10 M sarafotoxin the IGF and ET pathways [26] [27] [28] [29] [30] [31] [32] [33] . Endothelin production 6c (S6c; Phoenix Pharmaceuticals), a selective ETB-reis stimulated by insulin and IGF-I [26] [27] [28] [29] [30] [31] [32] , and vice-versa ceptor agonist [36] . In certain experiments, ET-1 or S6c 28 [33] . There are few data regarding the coronary vasoactive were added after 20 min of incubation with either 10 M interactions between the two pathways. Because both regular insulin (Eli Lilly, Indianapolis, IN, USA) or IGF-I insulin and IGF-I attenuate ET-1-induced calcium influx (Sigma). These concentrations of insulin and IGF-I were into porcine coronary artery smooth muscle [34] , we derived from preliminary experiments in which epicardial 27 postulated that they would also attenuate ET-1-induced arteries were first contracted with ET-1 (10 M) and then contraction of porcine coronary epicardial arteries in vitro.
relaxed with cumulative concentrations of either insulin (n54 vessels) or IGF-I (n54 vessels). The EC for both 50 28 peptides was found to be approximately 10 M.
Methods
To verify that the effect of insulin and IGF-I on the ET axis is unique, the above experiments were repeated using coronary vasorelaxing effects of insulin and IGF-I are through the regulation of calcium influx. In porcine In vitro determination of epicardial reactivity was coronary arterial strips, diltiazem at this dose has been performed as previously described [35] . In brief, the hearts shown to inhibit increases in intracellular calcium and were placed into cold modified Krebs-Ringer bicarbonate tension development induced by cumulative applications of solution of the following millimolar composition (control extracellular calcium during potassium-induced contraction solution): 118.3 NaCl, 4.7 KCl, 2.5 CaCl , 1.2 MgSO , 1.2 [37] . 2 4 KH PO , 25 NaHCO , 0.026 calcium ethylenediamineStock solutions of each agent were prepared every day. 2 4 3 tetraacetic acid and 11.1 glucose. Segments, 2-3 mm long, Drugs were dissolved in distilled water such that volumes of the left circumflex coronary artery were dissected. When of ,0.2 ml were added to the organ chambers. All indicated, the endothelium was mechanically removed concentrations are expressed as the concentration within
from the vessels. Each vessel was connected to an isothe bath solution. At the end of all experiments, 10 M metric force transducer (Grass Instruments, West Warwick, papaverine (Sigma) was added to verify that the vessels RI, USA) and suspended in an organ chamber filled with maintained vasodilating capacity. 25 ml of control solution (378C; pH 7.4) and gassed with 94% O and 6% CO . Isometric tension was recorded 2.3. Data analysis 2 2 continuously. The arteries were allowed to stabilize at a resting tension for 1 h. Viability of the vessels was Results are presented as mean6SEM. In experiments confirmed by a contractile response to 20 mM KCl at designed to examine the contractile responses, the contracbaseline, at 2 g, at 4 g and at 6 g, each time after the tion attained with 60 mM KCl for each vessel at baseline potassium had been washed out. At 6 g, all vessels were was considered as 100% contraction. Subsequent measure-26 then exposed to 10 M substance P (Sigma, St. Louis, ments of coronary artery contraction are expressed as a MO, USA), an endothelium-dependent vasodilator, to percent relative to the contraction attained with KCl. In all verify the functional integrity of the vascular endothelium.
experiments, n refers to the number of vessels. In experiAll chambers were then washed out using the control ments designed to examine the vasorelaxing effects of solution.
insulin and IGF-I, the contraction attained with ET-1 for After an equilibration period of 30 min, epicardial each vessel at baseline was considered as baseline (0% arteries were contracted with cumulative concentrations of relaxation). Subsequent measurements of coronary artery 210 26 either 10 -10 M ET-1 (Phoenix Pharmaceuticals, relaxation are expressed as a percent reduction in contrac-tion (the maximal relaxation attained with papaverine being 100% relaxation). Experiments were performed in parallel to preclude a situation whereby all vessels in one experiment were harvested from only one animal (on average, each experiment was conducted using vessels from three-four animals). For statistical analysis, ANOVA or repeated measure ANOVA followed by Bonferroni's t-test were used. A two-tailed p value of #0.05 was considered to be significant. mM KCl-induced vasoconstriction in endothelium-intact vessels, but did not cause any vasorelaxation in endo-3.3. Sarafotoxin 6 thelium-removed vessels. The mean response to 60 mM KCl in each protocol is presented in Table 1 . Although the The contractile response to S6c was significantly greater maximal response to 60 mM KCl was greater for endoin vessels without the endothelium: The maximal contracthelium-intact than endothelium-removed vessels (6.260.3 tions to S6c in vessels with and without endothelium were (Fig. 3 ) and without The contractile response to ET-1 was greater in vessels endothelium (Fig. 4) endothelium-removed vessels were 10 M and 10 6) exposed to the thromboxane A analog U46619 con-2 M, respectively ( p50.03). In vessels with intact endothelium, both insulin and IGF-I attenuated the response to ET-1 ( Fig. 1) , without affecting the EC . Similarly, in 50 vessels without endothelium, the response to ET-1 was attenuated by insulin and IGF-I (Fig. 2) , without affecting the EC . to ET-1 alone. tracted in a concentration-dependent manner (data not 4. Discussion shown). The EC for the contractile response to U46619 50 27.4 was 10 M. Insulin (n56) and IGF-I (n56) did not The principal finding of the current study was that both affect the contractile response to U46619 ( p50.95 and insulin and IGF-I attenuated ET-1-induced but not S6c-0.92 for insulin and IGF-I, respectively; Fig. 5 ). The EC 50 induced coronary epicardial contraction in vitro. Due to the values remained similarly unchanged ( p50.77 and 0.51, similar effects attained in vessels with and without endorespectively).
Results

Vessel integrity after endothelium removal
thelium, the effects of insulin and IGF-I were endotheliumindependent. The interaction between the ET and insulin / 3.
Vasorelaxing effects of insulin and IGF-I
IGF pathways has previously focused predominantly on the effect of each pathway on the production, secretion and Porcine epicardial arteries with intact endothelium were binding of the ligand of the other pathway [26] [27] [28] [29] [30] [31] [32] [33] , and on contracted with ET-1 and then exposed to cumulative their interplay in promoting cell proliferation [30] . Our concentrations of either insulin (n57) or IGF-I (n58).
findings extend the current paradigm regarding this interBoth insulin and IGF-I caused a significant decrease in action, demonstrating that the vasoactive effects of ET coronary epicardial tension (relaxation of 2864 and may be regulated by insulin or IGF-I. The lack of 2563% with insulin and IGF-I, respectively, p,0.0001 inhibition by either peptide of thromboxane-induced porfor each peptide). There was no significant difference in cine epicardial contraction, and more so the selective the vasorelaxation response attained with both agents.
inhibition of ET-1-induced but not S6c-induced coronary 26 Pre-incubation of the vessels with diltiazem (10 M, n56 contraction, indicate that this interaction is specific for the for each peptide) had no effect on the vasorelaxing effects ETA-receptor-mediated pathway. Moreover, the endoof either peptide (Fig. 6) .
thelium-independence of this interaction points to the coronary vascular smooth muscle cell as the primary locus.
Insulin and IGF-I may thus function as endogenous modulators of ET, a potent vasoconstrictor implicated in the pathogenesis of several pathophysiologic conditions [1, 2] .
Possible mechanisms
ET-1 increases porcine coronary artery smooth muscle calcium biphasically [34, 38] : First, it causes the release of calcium from intracellular stores and then it induces calcium influx via voltage-gated potassium channels. Dick and Sturek [34] have demonstrated that physiological concentrations of insulin blunt the ET-1-induced rise in porcine coronary artery smooth muscle cell calcium, perhaps by modulating transmembrane signal transduction. These authors [34] speculated that insulin's attenuating effect is not specific for ET-1, but rather is an effect lated. High concentrations of ET-1 (.10 nM) irreversibly exerted on all inositol 1,4,5-trisphosphate-mediated vasinhibit porcine coronary artery smooth muscle cell caloconstrictor agonists.
cium-activated potassium channels in vitro [45] . Others ETB-receptor stimulation, similarly to ETA-receptor have reported a similar effect in isolated guinea-pig ileum stimulation [34, 38, 39] , can cause an increase in intracellu- [46] . By inhibiting these channels, coronary tone is lar calcium [40] , via stimulation of inositol 1,4,5-trisphosenhanced, resulting in vascular contraction. The in vitro phate [41] . Because our results indicate that the interaction interaction between endothelins and porcine coronary between the ET and insulin / IGF pathways is limited to artery smooth muscle cell calcium-activated potassium activation of the ETA receptor, this interaction is probably channels has recently been shown to be mediated solely by unique and does not represent an indiscriminate attenuation the ETA receptor and not by the ETB receptor [47] . Insulin of vasoconstrictors by insulin and IGF-I, as proposed by and IGF-I may attenuate the vasoconstrictor effects of Dick and Sturek [34] .
ET-1 by activating these channels, in a similar way to their ET binding to vascular smooth muscle ETA and ETB effects on other types of potassium channels [48] . receptors mediates vasoconstriction, whereas ETB recepOur studies demonstrating the lack of effect of diltiazem tors on the vascular endothelium mediate a vasodilator on the vasorelaxing effects of insulin and IGF indicate that response, presumably through increased production and these peptides may affect ET-1-induced contraction release of nitric oxide and / or prostacyclin [42] , and through the regulation of intracellular calcium stores rather activation of potassium channels [2] . Indeed, in our than through the regulation of calcium influx into the studies, removal of the endothelium resulted in increased vascular smooth muscle cell. As mentioned above, ET-1-contraction to S6c and ET-1. However, in vessels without induced contraction of porcine coronary arteries initially endothelium, insulin and IGF-I did not attenuate the results in the release of calcium from intracellular pools vascular smooth muscle ETB-receptor-mediated response [34, 38] . Insulin and IGF-I may blunt this rise in intracelluto S6c, further supporting a unique interaction between the lar calcium. However, because insulin and IGF-I failed to IGF axis and the vascular smooth muscle ETA receptor.
attenuate the contractile response of another potent agent Moreover, Seo et al. [43] previously demonstrated that that causes the release of calcium from the intracellular the contractile response of porcine epicardial arteries to stores, U46619, the interaction between the ET-1 and endothelins is biphasic; the first phase attained at low insulin / IGF axes is probably more complex than just the concentrations is primarily mediated by the endothelin regulation of intracellular calcium kinetics. ETB receptor, whereas both endothelin receptors mediate contraction in the latter, more pronounced, phase attained 4.2. Concentration of insulin and IGF-I at high concentrations. We have confirmed these findings in porcine coronary arterioles [44] . It is thus of interest
In our experiments, we used supraphysiological conthat, in our current studies, both insulin and IGF-I atcentrations of insulin and IGF-I to attenuate the vasocontenuated the contractile response to high concentrations of strictor effects of ET-1. Unlike insulin, which is only ET-1 (i.e., mediated by both ETA and ETB receptors) but produced in the liver, IGF-I is produced by various cell not to low concentrations (i.e., mediated primarily by the types, including endothelial [49, 50] and vascular smooth ETB receptor).
muscle cells [51] [52] [53] . IGF-I may therefore serve as an The mechanisms underlying the attenuation of ET-1-endogenous paracrine / autocrine factor in the regulation of induced contraction by insulin and IGF-I may be specuregional vascular tone in physiological and
